Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers
- Ramesh K. Ramanathan
- , Marwan Fakih
- , Sridhar Mani
- , Melvin Deutsch
- , Raymond P. Perez
- , Mark A. Ritter
- , Julie L. Eiseman
- , S. Percy Ivy
- , Donald L. Trump
- , Chandra P. Belani
- , Robert A. Parise
- , Douglas M. Potter
- , Merrill J. Egorin
Research output: Contribution to journal › Article › peer-review
11
Link opens in a new tab
Scopus
citations